Bioline Rx reported $13.67M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Arca Biopharma USD 16.63M 1.26M Mar/2026
Bio Path USD 9.15M 468K Mar/2026
Bioline Rx USD 13.67M 1.81M Sep/2025
Capricor Therapeutics USD 33.64M 2.2M Mar/2026